Under bankruptcy, owners and financials
CVR: 42523453
DKK -38,812
Gross profit
Net result: DKK -1,033,166
Neurometa Therapeutics AB (90-99,99%)
CVR · view owners
No current management
CVR · view management
Under bankruptcy
Founded 6 July 2021
CVR · view overview
No headcount reported
Director role ended: Preben Bruun-Nyzell
CVR · 27/04/2026
View the full event history
2N Pharma Holding ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2021. The company is under bankruptcy. The company is registered under the industry Ikke-finansielle holdingselskaber. The company is owned by Neurometa Therapeutics AB. In 2024, the company reported a gross profit of DKK -38,812 and a net result of DKK -1,033,166 compared with DKK -948,734 the year before. Equity in the 2024 report amounted to DKK -2,165,476.
Virksomhedens formål er at eje kapitalandele i 2N Pharma ApS samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | -39K | -1M | 11.3M | -2.2M | - | |
| 202301/01/2023 – 31/12/2023 | -31K | -949K | 11.3M | -1.1M | - |
Ved dekret af 27. april 2026 har Retten i Aalborg taget 2N Pharma Holding ApS under konkursbehandling. Kurator: Advokat Peter Wedel Ranch Krarup, Amaliegade 10, 1256 København K. Sagsnr. SKS 31-190/2026.
Source: Statstidende, updated daily
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationYes. 2N Pharma Holding ApS is registered in the Danish CVR register with the status under bankruptcy. The bankruptcy decree is published in Statstidende.
The CVR number of 2N Pharma Holding ApS is 42523453.
2N Pharma Holding ApS is owned by Neurometa Therapeutics AB.
In 2024, 2N Pharma Holding ApS reported a gross profit of DKK -38,812.
2N Pharma Holding ApS was founded on 6 July 2021.
2N Pharma Holding ApS was registered under the industry Ikke-finansielle holdingselskaber (industry code 642120).
On September 29, 2026, 2N Pharma Holding ApS was placed under bankruptcy proceedings.
On April 29, 2026, a notice regarding 2N Pharma Holding ApS was published in Statstidende: Konkursdekret (S27042026-68).
As of April 27, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 2N Pharma Holding ApS.
As of April 27, 2026, Preben Bruun-Nyzell has left the board of directors of 2N Pharma Holding ApS.
As of April 27, 2026, Josephus Dirk Vestergaard Nieland has left the board of directors of 2N Pharma Holding ApS.
As of April 27, 2026, Preben Bruun-Nyzell has stepped down as adm. dir. of 2N Pharma Holding ApS.
As of April 27, 2026, Josephus Dirk Vestergaard Nieland has stepped down as director of 2N Pharma Holding ApS.
2N Pharma Holding ApS has published its annual report for 2024. Gross profit came to DKK -38,812, and the net result was DKK -1,033,166.
2N Pharma Holding ApS has published its annual report for 2023. Gross profit came to DKK -31,303, and the net result was DKK -948,734.
As of September 4, 2023, John Kemp has left the board of directors of 2N Pharma Holding ApS.
As of August 31, 2023, Alex Leech has left the board of directors of 2N Pharma Holding ApS.
2N Pharma Holding ApS has published its interim report for the period July 6, 2021 to December 31, 2022.
As of July 6, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2N Pharma Holding ApS.
As of July 6, 2021, Preben Bruun-Nyzell has joined the board of directors of 2N Pharma Holding ApS.
As of July 6, 2021, Josephus Dirk Vestergaard Nieland has joined the board of directors of 2N Pharma Holding ApS.
As of July 6, 2021, Alex Leech has joined the board of directors of 2N Pharma Holding ApS.
As of July 6, 2021, John Kemp has joined the board of directors of 2N Pharma Holding ApS.
As of July 6, 2021, Preben Bruun-Nyzell is registered as adm. dir. of 2N Pharma Holding ApS.
As of July 6, 2021, Josephus Dirk Vestergaard Nieland is registered as director of 2N Pharma Holding ApS.
As of July 6, 2021, is registered as an owner of 2N Pharma Holding ApS with an ownership share of 90%.
2N Pharma Holding ApS was founded on July 6, 2021.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er besidde kapitalandele i datterselskaber og associerede selskaber samt at drive investeringsvirksomhed samt enhver i forbindelse hermed beslægtet virksomhed.
Companies in the same industry and area
CVR 44234254
CVR 41128798
CVR 36400870
CVR 38690442
CVR 40293965
